ISSN: 1948-1432

Journal of Global Research in Computer Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


Hepatocellular carcinoma is one of the commonest deadly tumors, and it is usually diagnose at a late stage, when effective treatment is very difficult. Making its discovery before the development of later stage disease is challenging. Hepatocellular carcinoma represents one of the prevalent types cancers with the highest proportion in developing countries. There are many clinical and pathological staging systems for detecting Hepatocellular carcinoma, but none of them includes biological parameters as predictors for prognosis. The various clinical presentations commonly relate to the extent of hepatic reserve at time of diagnosis and so far, there are no studies that conclusively prove that screening hepatocellular carcinoma will reduce the death rate. The development of genome-wide analysis methods has opened the possibility of identifying multiple changes simultaneously in genetic or epigenetic alterations as well as in gene expression affecting the genome of cancer cells. The main issue raised by this work is to determine which alternatives can construed as reliable biomarkers for providing information about the carcinogenesis process rather using screening methods for detect hepatocellular carcinoma. This systematic review opens the door to Bioinformatics to discover novel cancer biomarkers that will help for early diagnosis of hepatocellular carcinoma. Identifying non-invasive and cost-effective biomarkers for early detection and personalized treatment of HCC will be one of the most promising fields of biomarker research. Find an effective, reliable tool for early diagnosis of HCC to increase the number of patients who are appropriate for therapeutic treatment will play a pivotal role in improving HCC patients’ prognosis. The traditional approaches to identify genomic alternations suffered from several inherent disadvantages, Next generation DNA sequence promises to revolutionize cancer research, diagnosis and therapy.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Esraa M. Hashem, Mai S. Mabrouk, Ayman M. Eldeib


Hepatocellular carcinoma, biomarker, screening methods, bioinformatics, next generation DNA sequence, HEPATOCELLULAR CARCINOMA,Biomedical Engineering

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version